James Douglas Battiste MD
Neurooncology
Instructor, Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center, Southwestern Medical School
Join to View Full Profile
800 NE 10th StOklahoma City, OK 73104
Phone+1 405-271-8001
Dr. Battiste is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Southwestern Medical CenterResidency, Neurology, 2007 - 2011
University of Texas Southwestern Medical SchoolClass of 2007
Certifications & Licensure
OK State Medical License 2013 - 2025
TX State Medical License 2009 - 2014
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- A phase Ib study evaluating the c-MET inhibitor INC280 (capmatinib) in combination with bevacizumab in patients with high-grade glioma.Gerald S Falchook, James D Battiste, Amandeep Kalra, Mythili Shastry, Lindsey Finney
Neuro-Oncology Advances. 2024-12-11 - 3 citationsEfficacy of Adding Veliparib to Temozolomide for Patients With MGMT-Methylated Glioblastoma: A Randomized Clinical Trial.Jann N Sarkaria, Karla V Ballman, Sani H Kizilbash, Erik P Sulman, Caterina Giannini
JAMA Oncology. 2024-12-01 - In Reply to the Letter to the Editor Regarding "Genetically Distinct Oligosarcoma Arising from Oligodendroglioma: Systematic Review & Illustrative Case Example".Alexander R Evans, Kiana Y Prather, James Battiste, Kar-Ming Fung, Ian F Dunn
World Neurosurgery. 2024-09-01
Press Mentions
Northwest Biotherapeutics: Data Is Done, Just Wait for ApprovalNovember 23rd, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
